Comparing AutoDock and Vina in Ligand/Decoy Discrimination for Virtual Screening
Source abstract
Abstract
AutoDock and Vina are two of the most widely used protein–ligand docking programs. The fact that these programs are free and available under an open source license, also makes them a very popular first choice for many users and a common starting point for many virtual screening campaigns, particularly in academia. Here, we evaluated the performance of AutoDock and Vina against an unbiased dataset containing 102 protein targets, 22,432 active compounds and 1,380,513 decoy molecules. In general, the results showed that the overall performance of Vina and AutoDock was comparable in discriminating between actives and decoys. However, the results varied significantly with the type of target. AutoDock was better in discriminating ligands and decoys in more hydrophobic, poorly polar and poorly charged pockets, while Vina tended to give better results for polar and charged binding pockets. For the type of ligand, the tendency was the same for both Vina and AutoDock. Bigger and more flexible ligands still presented a bigger challenge for these docking programs. A set of guidelines was formulated, based on the strengths and weaknesses of both docking program and their limits of validation.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Computational Drug Discovery Methods · Microbial Natural Products and Biosynthesis · Protein Structure and Dynamics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
UCIBIO@REQUIMTE, BioSIM—Departamento de Biomedicina, Faculdade de Medicina da Universidade do Porto, 4200-319 Porto, Portugal
Funding
Fundação para a Ciencia e a Tecnologia
References (55)
Show source-provided references
1. Docking and Scoring in Virtual Screening for drug discovery: Methods and applications10.1038/nrd1549 ↗
2. Kinnings, S.L., Liu, N., Buchmeier, N., Tonge, P.J., Xie, L., and Bourne, P.E. (2009). Drug discovery using chemical systems biology: Repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis. PLoS Comput. Biol., 5.10.1371/journal.pcbi.1000423 ↗
3. Drug repositioning by structure-based virtual screening10.1039/c2cs35357a ↗
4. Large-scale computational drug repositioning to find treatments for rare diseases10.1038/s41540-018-0050-7 ↗
5. Protein—Ligand Docking: Current Status and Future Challenges10.1002/prot.21082 ↗
6. Virtual screening in drug design and development10.2174/138620710791293001 ↗
7. A Practical Guide to Molecular Docking and Homology Modelling for Medicinal Chemists10.2174/1568026617666170130110827 ↗
8. Protein-Ligand Docking in the New Millennium—A Retrospective of 10 Years in the Field10.2174/0929867311320180002 ↗
9. Molecular docking and structure-based drug design strategies10.3390/molecules200713384 ↗
10. Structure-based drug design: Docking and scoring10.2174/138920307781369382 ↗
11. A review of protein-small molecule docking methods10.1023/A:1020155510718 ↗
12. Advances and challenges in Protein-ligand docking10.3390/ijms11083016 ↗
13. Structure-Based Virtual Screening for Drug Discovery: A Problem-Centric Review10.1208/s12248-012-9322-0 ↗
14. Multiple grid arrangement improves ligand docking with unknown binding sites: Application to the inverse docking problem10.1016/j.compbiolchem.2018.02.008 ↗
15. Flexible ligand docking to multiple receptor conformations: A practical alternative10.1016/j.sbi.2008.01.004 ↗
16. Comprehensive assessment of flexible-ligand docking algorithms: Current effectiveness and challenges10.1093/bib/bbx030 ↗
17. Importance of protein flexibility in molecular recognition: A case study on Type-I1/2 inhibitors of ALK10.1039/C7CP08241J ↗
18. Quantifying water-mediated protein-ligand interactions in a glutamate receptor: A DFT study10.1021/jp200776t ↗
19. Munawar, S., Vandenberg, J.I., and Jabeen, I. (2019). Molecular Docking Guided Grid-Independent Descriptor Analysis to Probe the Impact of Water Molecules on Conformational Changes of hERG Inhibitors in Drug Trapping Phenomenon. Int. J. Mol. Sci., 20.10.3390/ijms20143385 ↗
20. Docking small peptides remains a great challenge: An assessment using AutoDock Vina10.1093/bib/bbv008 ↗
21. LEADS-PEP: A Benchmark Data Set for Assessment of Peptide Docking Performance10.1021/acs.jcim.5b00234 ↗
22. Dynamics and binding interactions of peptide inhibitors of dengue virus entry10.1007/s10867-018-9515-6 ↗
23. Receptor-based virtual screening protocol for drug discovery10.1016/j.abb.2015.05.011 ↗
24. Ramírez, D., and Caballero, J. (2016). Is it reliable to use common molecular docking methods for comparing the binding affinities of enantiomer pairs for their protein target?. Int. J. Mol. Sci., 17.10.3390/ijms17040525 ↗
25. Small Molecule Docking and Scoring
26. Comparing protein-ligand docking programs is difficult10.1002/prot.20497 ↗
27. Evaluation of Docking Performance: Comparative Data on Docking Algorithms10.1021/jm0302997 ↗
28. Comparing sixteen scoring functions for predicting biological activities of ligands for protein targets10.1016/j.jmgm.2015.01.009 ↗
29. Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: The prediction accuracy of sampling power and scoring power10.1039/C6CP01555G ↗
30. Tailoring specialized scoring functions for more efficient virtual screening
31. Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking10.1021/jm300687e ↗
32. Bartuzi, D., Kaczor, A., Targowska-Duda, K., and Matosiuk, D. (2017). Recent Advances and Applications of Molecular Docking to G Protein-Coupled Receptors. Molecules, 22.10.3390/molecules22020340 ↗
33. BACE1 inhibitory activity and molecular docking analysis of meroterpenoids from Sargassum serratifolium10.1016/j.bmc.2017.05.033 ↗
34. Docking and ADMET prediction of few GSK-3 inhibitors divulges 6-bromoindirubin-3-oxime as a potential inhibitor10.1016/j.jmgm.2016.03.001 ↗
35. Ravindranath, P.A., Forli, S., Goodsell, D.S., Olson, A.J., and Sanner, M.F. (2015). AutoDockFR: Advances in Protein-Ligand Docking with Explicitly Specified Binding Site Flexibility. PLoS Comput. Biol., 11.10.1371/journal.pcbi.1004586 ↗
36. MTiOpenScreen: A web server for structure-based virtual screening10.1093/nar/gkv306 ↗
37. AutoDock VinaXB: Implementation of XBSF, new empirical halogen bond scoring function, into AutoDock Vina10.1186/s13321-016-0139-1 ↗
38. Quiroga, R., and Villarreal, M.A. (2016). Vinardo: A scoring function based on autodock vina improves scoring, docking, and virtual screening. PLoS ONE, 11.10.1371/journal.pone.0155183 ↗
39. DockingApp: A user-friendly interface for facilitated docking simulations with AutoDock Vina10.1007/s10822-016-0006-1 ↗
40. Software news and updates AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility10.1002/jcc.21256 ↗
41. Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.410.1007/BF00124499 ↗
42. Automated docking of flexible ligands: Applications of AutoDock10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6 ↗
43. Automated Docking Using a Lamarckian Genetic Algorithm and an Empirical Binding Free Energy Function10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B ↗
44. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading10.1002/jcc.21334 ↗
45. 1001 Ways to run AutoDock Vina for virtual screening10.1007/s10822-016-9900-9 ↗
46. Ligand Pose and Orientational Sampling in Molecular Docking10.1371/journal.pone.0075992 ↗
47. DOCK 6: Impact of new features and current docking performance10.1002/jcc.23905 ↗
48. Benchmark of four popular virtual screening programs: Construction of the active/decoy dataset remains a major determinant of measured performance10.1186/s13321-016-0112-z ↗
49. Uehara, S., and Tanaka, S. (2016). AutoDock-GIST: Incorporating Thermodynamics of Active-Site Water into Scoring Function for Accurate Protein-Ligand Docking. Molecules, 21.10.3390/molecules21111604 ↗
50. Machine Learning Consensus Scoring Improves Performance Across Targets in Structure-Based Virtual Screening10.1021/acs.jcim.7b00153 ↗
51. FINDSITE comb2.0: A New Approach for Virtual Ligand Screening of Proteins and Virtual Target Screening of Biomolecules10.1021/acs.jcim.8b00309 ↗
52. Ligity: A Non-Superpositional, Knowledge-Based Approach to Virtual Screening10.1021/acs.jcim.8b00779 ↗
53. Wang, D., Cui, C., Ding, X., Xiong, Z., Zheng, M., Luo, X., Jiang, H., and Chen, K. (2019). Improving the Virtual Screening Ability of Target-Specific Scoring Functions Using Deep Learning Methods. Front. Pharmacol., 10.10.3389/fphar.2019.00924 ↗
54. DLIGAND2: An improved knowledge-based energy function for protein–ligand interactions using the distance-scaled, finite, ideal-gas reference state10.1186/s13321-019-0373-4 ↗
55. (2019, October 18). Molecular Operating Environment (MOE), 2013.08; Chemical Computing Group ULC, Montreal, Canada. Available online: https://www.chemcomp.com/index.htm.